Tag Archives: Allena Pharmaceuticals Inc

Wedbush Reaffirms Their Buy Rating on Allena Pharmaceuticals Inc (ALNA)

Wedbush analyst Liana Moussatos reiterated a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report) today and set a price target of $26.00. The company’s shares closed last Monday at $5.20. According to TipRanks.com, Moussatos is currently ranked with

Cowen & Co. Thinks Allena Pharmaceuticals Inc’s Stock is Going to Recover

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report). The company’s shares closed yesterday at $3.96, close to its 52-week low of $3.62. According to TipRanks.com,

Wedbush Thinks Allena Pharmaceuticals Inc’s Stock is Going to Recover

Wedbush analyst Liana Moussatos reiterated a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report) today and set a price target of $36. The company’s shares opened today at $4.49, close to its 52-week low of $3.92. According to

Allena Pharmaceuticals Inc (ALNA) Receives a Buy from B.Riley FBR

B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report) on May 20 and set a price target of $22. The company’s shares closed yesterday at $5.06, close to its 52-week low of

Cowen & Co. Keeps Their Buy Rating on Allena Pharmaceuticals Inc (ALNA)

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report) yesterday. The company’s shares closed yesterday at $5.74, close to its 52-week low of $4.80. According to TipRanks.com, Baral is a top

Allena Pharmaceuticals Inc (ALNA) Gets a Buy Rating from Wedbush

Wedbush analyst Liana Moussatos reiterated a Buy rating on Allena Pharmaceuticals Inc (ALNA – Research Report) today and set a price target of $39. The company’s shares closed on Friday at $6.87, close to its 52-week low of $4.80. According